Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Francesca.Hutton@globaldata.com

  • Home
  • Author: Francesca.Hutton@globaldata.com

Future of drug-coated devices in peripheral interventions put into question after FDA preliminary review, says GlobalData

Following the news that the FDA recently announced that its preliminary review of long-term follow-up data of people with peripheral artery disease being treated by paclitaxel-coated devices, compared with bare devices, revealed a “potentially concerning signal” of increased risk of mortality rates, Sheryl Tang, Medical Devices analyst at GlobalData offers her view: “GlobalData estimates that […]
Read more

Phase III failure for Pollinex Quattro Birch puts Allergy Therapeutics in a precarious position for long-awaited US expansion, says GlobalData

On 18 March 2019, Allergy Therapeutics announced that its Phase III pivotal trial for Pollinex Quattro (PQ) Birch, an ultra-short course birch pollen allergen immunotherapy, failed to meet the primary endpoint of a statistically significant difference between active and placebo arms in the combined symptom and medication score (CSMS) averaged over peak birch pollen season. […]
Read more

DRC Ebola outbreak shows vaccine limitations in overcoming non-clinical obstacles to control infectious diseases, says GlobalData

Following comments from CDC director Robert Redfield (Friday 15 March) that establishing control over the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC) could take up to a year or longer, Christopher J. Pace, Director of Infectious Diseases at GlobalData, a leading data and analytics company, offers his view on the challenges […]
Read more

Electrophysiology catheters global market set to reach $3.9bn by 2028, says GlobalData

The global electrophysiology catheters market is expected to reach $3.9bn by 2028, growing at a compound annual growth rate (CAGR) of 4.1%, according to GlobalData, a leading data and analytics company. The company’s reports, ‘Electrophysiology Ablation Catheters – Cardiovascular Market Analysis and  Forecast Model’ and  ‘Electrophysiology Diagnostic Catheters – Cardiovascular Market Analysis and Forecast Model’ […]
Read more

3D Printing is a potential game changer for global power market, according to GlobalData

One of the most innovative and disruptive technological advancements that will transform the global power industry is 3D printing (Additive Manufacturing), says GlobalData, a leading data and analytics company. Recently, additive manufacturing (AM) has found its application in different sectors of the power industry, both in building prototypes and in main stream production leading to […]
Read more

JD Sports can breathe new life into Footasylum, says GlobalData

Following the news that JD Sports is to buy Footasylum for £90m, Patrick O’Brien, UK Retail Research Director offers his view: “While JD Sports is paying a 77% premium on Friday’s closing price, the 82.5p bid is almost half of Footasylum’s IPO offer price when it listed just 16 months ago. “Footasylum went for rapid […]
Read more

Germany’s partnership with CARB-X is a critical step in the global push against antibiotics resistance, says GlobalData

Following the news on March 14, 2019 that Germany’s Federal Ministry of Education and Research (BMBF) has committed €40 million to CARB-X for early development of antibiotics, Paul Jeng, PhD, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on global efforts to combat the threat of antibiotics resistance: “Antimicrobial resistance […]
Read more

Pfizer’s Trazimera set to challenge Roche’s Herceptin as fourth competitor in HER2 Positive oncology market, says GlobalData

On 11th March 2019, Pfizer Inc announced the FDA had approved Trazimera (trastuzumab-qyyp), a biosimilar to Roche’s Herceptin (trastuzumab) for the treatment of human epidermal growth factor receptor-2 (HER2) overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. Amrita Gujral, Pharma Analyst at GlobalData, a leading data and analytics company, offers her […]
Read more

In the event of a ‘no deal’ Brexit, UK healthcare industry will take years to stabilize, says GlobalData

It may take up to five years for the healthcare industry to stabilize in the event of a ‘no deal’ Brexit. This is the consensus opinion among professionals surveyed in the pharmaceutical industry, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Brexit and the Healthcare Industry – Implications for Pharma – […]
Read more

ECCO 2019: Entyvio set to be most dominant drug in the UC landscape following VARSITY trial, says GlobalData

The results of the VARSITY trial, a head-to-head Phase IIIb double-blind, double-dummy, multicentre, active controlled study, that evaluates the efficacy and safety of Entyvio, compared to Humira in patients with moderate to severe ulcerative colitis (UC), were announced at the ECCO Conference 2019 in Copenhagen. Following this, Patrick Aiyes, Pharma Analyst at GlobalData, a leading […]
Read more

Deutsche and Commerzbank merger talks prompted by fears of foreign takeover, says GlobalData

Following the news of merger talks between Germany’s two largest banks, Deutsche and Commerzbank, Sean Harrison, Banking Analyst at GlobalData, a leading data and analytics company offers his comment: “These merger talks are unsurprising. Both banks have had a torrid time, suffering from poor profitability and inefficient operations. According to GlobalData’s Global Retail Banking Analytics tool […]
Read more

As National Colorectal Cancer Awareness Month draws attention to the disease, colorectal cancer screening tests market expected to surpass $2bn by 2028, says GlobalData

March is National Colorectal Cancer (CRC) Awareness Month, a time aimed at raising disease awareness and preventing future incident cases, primarily by encouraging individuals to participate in CRC screening programs. Alison Casey, Medical Devices analysts at GlobalData, commented, “Aging populations and increasing disease awareness mean that CRC screening has become a priority for many countries. […]
Read more
1 … 5 6 7 8 9 … 16